CARBAMAZEPINE ER
- Product NDC
- 35561-355
- 11-digit product format
- 355610355
- Labeler code
- 35561
- Product ID
- 35561-355_5094cfb0-cf09-008b-e063-6394a90a402f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbamazepine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bostal LLC
- Application
- ANDA215591
- Marketing category
- ANDA
- Marketing start
- 2022-03-31
- Substance
- CARBAMAZEPINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CARBAMAZEPINE ER
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARBAMAZEPINE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 33CM23913M |
| Rxcui | 199378, 402505, 402506 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 35561-355-12 | 2026-01-29 | C162847 | 48780-1 | 49896155-c2f9-586f-e063-e6dba90add90 | Carbamazepine Extended-Release Tablets, USP 100 mg, 200 mg, 400 mg Rx only Prescribing Information |
| 35561-355-12 | 2026-01-29 | C162847 | 48780-1 | 49896155-c2f9-586f-e063-e6dba90add90 | Carbamazepine Extended-Release Tablets, USP 100 mg, 200 mg, 400 mg Rx only Prescribing Information |
| 35561-355-12 | 2026-01-29 | C162847 | 48780-1 | 49896155-c2f9-586f-e063-e6dba90add90 | Carbamazepine Extended-Release Tablets, USP 100 mg, 200 mg, 400 mg Rx only Prescribing Information |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 35561-355-12 | CARBAMAZEPINE ER | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 9 |
| 35561-355-13 | CARBAMAZEPINE ER | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | | 9 |
| 35561-355-26 | CARBAMAZEPINE ER | 30 in 1 CARTON | TABLET, EXTENDED RELEASE | 30 | | 9 |
| 35561-355-99 | CARBAMAZEPINE ER | 125729 in 1 DRUM | TABLET, EXTENDED RELEASE | 125729 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 35561-355 | CARBAMAZEPINE ER (CARBAMAZEPINE) TABLET, EXTENDED RELEASE [AUSTARPHARMA LLC] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241027_b48741b3-0889-47b8-a26e-b12614f6e7fc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 35561-355-12 | 35561035512 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (35561-355-12) | 2022-03-31 | 0000-00-00 | No | No | Current |
| 35561-355-13 | 35561035513 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (35561-355-13) | 2025-04-09 | | No | No | Historical |
| 35561-355-26 | 35561035526 | 30 in 1 CARTON | | | | | Historical |
| 35561-355-99 | 35561035599 | 125729 TABLET, EXTENDED RELEASE in 1 DRUM (35561-355-99) | 2025-04-27 | | No | No | Historical |